Abbvie Inc. $7,107,127 Acelyrin, Inc. $195,000 Neumora Therapeutics, Inc. $4,045,519 Abbvie Inc. $7,107,127 Acelyrin, Inc. $195,000 Neumora Therapeutics, Inc. $4,045,519